BioAtla, Inc. 8-K Filing: Key Insights on Recent Corporate Changes

Based on the provided section of the financial report, here are the key pieces of information and insights:

1. Filing Information:

• Form Type: 8-K, which is used to report unscheduled material events or corporate changes that are of importance to shareholders.
• Filing Date: December 20, 2024.
  

2. Entity Details:

• Company Name: BioAtla, Inc.
• CIK Number: 0001826892, an identifier used by the SEC to identify the company.
• State of Incorporation: Delaware (DE).
• SEC File Number: 001-39787.
• EIN: 85-1922320, which is the Employer Identification Number.

3. Contact Information:

• Address: 11085 Torreyana Road, San Diego, CA 92121.
• Phone Number: 858-558-0708.

4. Stock Information:

• Stock Type: Common Stock.
• Par Value: $0.0001 per share.
• Trading Symbol: BCAB, listed on NASDAQ.

5. Reporting Period:

• The report references a specific date (December 20, 2024), indicating the report might relate to a specific event or situation occurring on this date.

Insights:

• The filing suggests that BioAtla, Inc. may have experienced a significant event or change on December 20, 2024, that warranted an 8-K filing.
• The company's listing on NASDAQ under the ticker BCAB indicates public trading and potential interest from investors.
• The low par value of the common stock ($0.0001) might imply a high number of shares outstanding, which is common in biotech companies to facilitate capital raising.

This section provides a foundational understanding of the company and its recent disclosure, valuable for investors and analysts monitoring corporate activities.